Hologic, Inc.
Hologic 別名
Women's Health Products
Breast Health
Gynecological Health
Sexual Health
Body Composition
Skeletal Health
Mammography Services
SureCare Service Plans
Diagnostic Imaging
Surgical Instruments
Diagnostic Testing
会社名
Group 親会社 子会社 得意先 仕入先 業務提携 銀行等 株主等

21 件
日付概要
1985年 FDA clears the first nucleic acid test.
1987年 Hologic introduces the first dual-energy X-ray absorptiometry system for evaluating osteoporosis.
1988年 FDA clears the first molecular diagnostic test kit for a sexually transmitted infection.
1995年 FDA approves the Rapid fFN® test.
1996年 FDA approves the ThinPrep® Pap test, liquid-based cytology for cervical cancer screening.
2001年 FDA approves the NovaSure® endometrial ablation treatment for abnormal uterine bleeding (AUB).
2002年 FDA approves the Selenia® mammography system–the beginning of a new era in breast cancer screening.
2002年 FDA approves the first nucleic acid test for screening donated blood prior to transfusion.
2003年 Release of the Tigris® DTS® system for automated screening of sexually transmitted infections (STIs).
2008年 FDA approves the Procleix® Ultrio®* triplex blood screening assay for HIV-1, hepatitis B and C.
2011年 FDA approves the breakthrough Selenia Dimensions®
2011年 FDA approves the breakthrough Selenia Dimensions® digital tomosynthesis system with the Hologic 3D Mammography™ exam.
2012年 FDA clears the Panther® system, an automated, integrated molecular platform, for use with the Aptima Combo 2® assay.
2014年 FDA clears the use of the bone densitometer for assessing three critical health problems, including osteoporosis.
2015年 CE marked virology portfolio, including Aptima® HIV, HCV and HBV assays, along with the Aptima® M. genitalium assay.
2016年 FDA clears the new Affim® prone biopsy system.
2017年 FDA approves Aptima® HIV-1 Quant assay, Aptima® HCV Quant DX assay, and the Aptima® HSV 1 & 2 assay. The Panther Fusion® respiratory assays were approved on the Panther Fusion system.
2017年 The Brevera® breast biopsy system with CorLumina® imaging technology combines tissue acquisition, real-time imaging, verification and advanced tissue handling.
2018年 FDA clears Clarity HD high-resolution 3D™ imaging and the SmartCurve™ breast stabilization system, providing superior image quality and a clinically proven solution for a more comfortable mammogram.
2019年 The FDA grants clearance to the new Aptima® BV and Aptima® CV/TV assays, which provide an accurate and objective method for diagnosing vaginitis.
2020年 FDA grants Emergency Use Authorization (EUA) for the Panther Fusion® SARS-CoV-2 and Aptima® SARS-CoV-2 assays, molecular diagnostic tests detecting the novel coronavirus.
+ 開くと読み込みます
2026-07-10 20:33 (Model: ggml-org/gpt-oss-20b )
↑